Jace Tabah-Jones

Montreal, QC H3G1Y6, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

N-terminal acetylation reduces synuclein pathology in models of Parkinson's disease.

N-terminal acetylation reduces synuclein pathology in models of Parkinson's disease.

Journal: Neurobiology of disease

Published: March 29, 2026

Correction: The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.

Correction: The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.

Journal: Molecular neurodegeneration

Published: December 19, 2024

The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.

The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.

Journal: Research square

Published: April 02, 2024

Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress.

Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 28, 2024

The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.

The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.

Journal: Molecular neurodegeneration

Published: February 22, 2024

The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.

The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.

Journal: bioRxiv : the preprint server for biology

Published: November 28, 2023

Comparing the signaling and transcriptome profiling landscapes of human iPSC-derived and primary rat neonatal cardiomyocytes.

Comparing the signaling and transcriptome profiling landscapes of human iPSC-derived and primary rat neonatal cardiomyocytes.

Journal: Scientific reports

Published: February 22, 2023

Gβγ subunits colocalize with RNA polymerase II and regulate transcription in cardiac fibroblasts.

Gβγ subunits colocalize with RNA polymerase II and regulate transcription in cardiac fibroblasts.

Journal: The Journal of biological chemistry

Published: January 01, 2023

Targeting G Protein-Coupled Receptors in the Treatment of Parkinson's Disease.

Targeting G Protein-Coupled Receptors in the Treatment of Parkinson's Disease.

Journal: Journal of molecular biology

Published: September 19, 2022

Tools for drug discovery and disease modeling- the future is upon us.

Tools for drug discovery and disease modeling- the future is upon us.

Journal: Methods (San Diego, Calif.)

Published: February 13, 2022

Measuring hypertrophy in neonatal rat primary cardiomyocytes and human iPSC-derived cardiomyocytes.

Measuring hypertrophy in neonatal rat primary cardiomyocytes and human iPSC-derived cardiomyocytes.

Journal: Methods (San Diego, Calif.)

Published: November 11, 2021

The Signaling and Pharmacology of the Dopamine D1 Receptor.

The Signaling and Pharmacology of the Dopamine D1 Receptor.

Journal: Frontiers in cellular neuroscience

Published: November 01, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026